Latest News Releases From The Newsroom
Breaking News: AMC's $325.5M Equity Raise and Draganfly's Defense Orders
September 14th, 2023
AMC Entertainment Holdings, Inc. (NYSE: AMC) said that it successfully raised approximately $325.5 million in new equity capital by selling 40 million shares at an average price of around $8.14 per share, before commissions and fees. $AMC was trad. Read more
Redburn Partners: Carnival and Norwegian Cruise Line are a Buy
September 14th, 2023
Carnival Corporation & plc (NYSE: CCL), a leading cruise line company, has been upgraded by Redburn Partners from Neutral to Buy, along with a price target of $23. With $CCL closing at $15.02 on Wednesday, this price target suggests a potential up. Read more
Semtech Posts Upbeat Results, Outlook Falls Short; FDA Panel Backs Alnylam's Patisiran
September 13th, 2023
Semtech Corporation (Nasdaq: SMTC), a technology company specializing in semiconductor solutions, reported earnings of $0.11 per share for the second quarter of fiscal 2024, surpassing the consensus EPS estimate of $0.02. Quarterly sales for Semtech . Read more
IBEX Misses Estimates, Guides Revenue Below-Consensus
September 13th, 2023
IBEX Limited (Nasdaq: IBEX), a company specializing in customer support solutions, reported earnings of $0.33 per share for the fourth quarter of fiscal 2023. This figure fell short of the consensus EPS estimate of $0.49. Quarterly sales for IBEX amo. Read more
REV Group Beats Estimates; Bullish View On Immunocore
September 13th, 2023
REV Group, Inc. (NYSE: REVG) exceeded expectations in its third-quarter fiscal 2023 earnings report, posting adjusted earnings of $0.35 per share compared to the consensus EPS estimate of $0.23. The company also outperformed in terms of quarterly sal. Read more
Spirit Airlines Lowers Outlook; Alnylam Stock Halted Amid FDA Panel Review
September 13th, 2023
Shares of Spirit Airlines, Inc. (NYSE: SAVE) experienced a dip in pre-market trading as it revised downwardly its third-quarter 2023 outlook. The company now anticipates revenues between $1.245 billion and $1.255 billion, a notable decrease from its . Read more
Momentum Builds: Workhorse's IRS Determination; Edgio's Upbeat Q2 Results
September 13th, 2023
Shares of Workhorse Group Inc. (Nasdaq: WKHS) soared over 20% in after-hours trading following the company's announcement of IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit. This approval opens the door for Workhorse . Read more
InnovAge Posts Mixed Results; Lockheed Martin Bags $841.4M+ Contract Modification
September 12th, 2023
InnovAge Holding Corp. (Nasdaq: INNV), a healthcare company, posted a fourth-quarter fiscal 2023 loss of $(0.09) per share, falling short of the consensus estimate loss of $(0.03). Nevertheless, the company reported quarterly sales of $176.87 million. Read more
Breaking: Asset Sale Deal Ignites Avalo Therapeutics
September 12th, 2023
Shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) surged by more than 40% following the company's announcement of a purchase agreement with AUG Therapeutics, LLC (AUG), wherein it will sell its rights, assets, and interests related to the 800 Series . Read more
Sight Sciences Takes a Hit: Revenue Outlook Falls Short
September 11th, 2023
Shares of Sight Sciences, Inc. (Nasdaq: SGHT) took a sharp nosedive in after-hours trading, plummeting over 15%. This drastic drop followed the company's announcement that its third-quarter 2023 total revenue is expected to be in the range of $19.0 m. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
February 27th, 2026February 26th, 2026
Treasury Sanctions Nicaraguan Officials Enabling the Murillo-Ortega Dictatorship's Repression
February 26th, 2026Kansas City Storm Names Cecil Stockdale as Head Coach for 2026 NJCP Season
February 26th, 2026




Member Login